Columbia Large Cap Growth ETF (REGS)

The Columbia Large Cap Growth ETF (REGS) is an actively managed fund that picks large-cap US growth stocks—the companies Columbia’s analysts believe will expand earnings and value over years—rather than mechanically following a growth index.

What is REGS really doing?

REGS employs Columbia Threadneedle’s equity team to hunt for large-cap US companies (those in the S&P 500 or nearby) that the team believes will compound earnings faster than the market expects. Unlike a passive growth-index fund, which holds all large-cap growth stocks in proportion to their market value, REGS concentrates its portfolio on roughly 100 to 150 names that Columbia’s analysts have highest conviction in. This means REGS can have very different weightings from a broad growth index: it might be heavily overweight to certain software or healthcare companies where Columbia sees competitive moats, and underweight or absent from others where the team sees trouble ahead.

How does the growth-stock framework work?

Growth stocks are companies that are expected to expand their earnings faster than the overall economy. The most celebrated growth businesses—software platforms, biotech companies with expanding product pipelines, digital commerce operators—can compound their earnings for years. Investors are willing to pay premium valuations (high price-to-earnings ratios) for these companies because they expect the earnings to eventually justify the premium. REGS’ portfolio is built on this logic: own businesses where Columbia sees multiyear earnings expansion and where the market has not yet fully appreciated the scale of that expansion. This is different from value investing, which hunts for cheap stocks with hidden worth; growth investing bets on businesses that everyone agrees are good but that will turn out to be even better.

What sectors does REGS favor?

Technology and healthcare are the natural homes for growth companies, because innovation in those sectors drives durable earnings expansion. REGS typically has significant weightings to software, semiconductors, digital services, and healthcare businesses. But growth stocks can live elsewhere too: a consumer-staples company that is successfully launching new product categories, a financial-services firm that is winning market share through superior technology, or an industrial company that is expanding into higher-margin segments. REGS’ sector mix reflects wherever Columbia’s research team sees the best growth opportunities, not a fixed template.

Is active management worth the cost?

That is the central question. REGS charges an active-management expense ratio—higher than a passive large-cap growth index ETF, but lower than a traditional mutual fund because the ETF structure reduces costs. The question becomes: does Columbia’s stock-picking alpha (its outperformance relative to the index) exceed the expense-ratio drag? Columbia has a track record in large-cap growth investing, but track records are not guarantees. If the fund’s picks underperform the index for several years in a row, the active fee becomes deadweight. If the picks outperform, the fee is invisible because the net returns are still excellent. An investor in REGS is explicitly betting that Columbia’s research will beat the market; someone seeking growth exposure could simply buy a passive large-cap growth index fund for a fraction of the cost.

What are the risks?

Concentration is the biggest. REGS owns roughly 150 large-cap stocks, which is concentrated relative to a broad market index (500+ stocks) but diversified within the growth universe. If Columbia’s research team misses a major structural shift—if the economics of software suddenly change, or healthcare regulations shift in unexpected ways—concentrated growth portfolios can swing hard. Valuation matters too: growth stocks trade on the market’s expectations about future earnings. If those expectations prove too optimistic, or if interest-rate rises make future earnings less valuable in present-value terms, growth multiples compress and the fund can lag. A market favoring value or defensive stocks while growth stumbles is a difficult environment for REGS.

Who should own REGS, and how to research it?

REGS is suited for investors with a longer time horizon (5+ years) who believe in Columbia’s growth-stock methodology and can tolerate the volatility that comes with concentrated growth investing. Someone needing capital appreciation rather than income, and comfortable backing a specific team’s stock-picking skill, might find REGS attractive. To research it, start with Columbia’s track record in large-cap growth investing: did the team outperform a comparable growth index over full market cycles? Look at the portfolio’s biggest holdings: are they genuinely high-quality growth businesses, or does the fund seem to have chased momentum? Check REGS’ volatility and drawdowns in declining markets: growth stocks typically fall harder than the broad market. Compare the fund’s long-term returns to a passive large-cap growth ETF after subtracting the expense ratio: the passive fund’s net return is REGS’ hurdle rate. If REGS has not beaten that hurdle over multiple years, the active fee is not paying for itself, and a simpler index fund is the better choice.